Medifast Announces Second Quarter 2022 Financial Results and Updated Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Medifast (MED) Tops Q2 EPS by 64c; Lowers Outlook
August 3, 2022 4:14 PM EDTMedifast (NYSE: MED) reported Q2 EPS of $3.87, $0.64 better than the analyst estimate of $3.23. Revenue for the quarter came in at $453.3 million versus the consensus estimate of $447.87 million.
GUIDANCE:
Medifast sees FY2022 EPS of $12.70-$14.10, versus the consensus of $15.38. Medifast sees... More
